Ligand Pharmaceuticals (LGND) Invested Capital (2011 - 2024)
Ligand Pharmaceuticals (LGND) reported Invested Capital of $73000.0 for Q4 2024, up 180.77% on a YoY basis from $26000.0 in Q1 2024, and up 180.77% sequentially from $26000.0 in Q4 2023.
Ligand Pharmaceuticals (LGND) Invested Capital (2011 - 2024) Analysis & Trends
Ligand Pharmaceuticals (LGND) has 12 years of Invested Capital data on file, last reported at $73000.0 in Q4 2024.
- For the quarter ending Q4 2024, Invested Capital rose 180.77% year-over-year to $73000.0; the trailing twelve-month figure through Sep 2025 stood at $73000.0 (up 180.77% YoY), and the FY2024 full-year result was $73000.0, up 180.77% from the prior year.
- Invested Capital advanced to $73000.0 in Q4 2024, from $26000.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $115.0 million in Q2 2022 to a low of $26000.0 in Q4 2023.
- A 5-year average of $34.4 million and a median of $3.4 million in 2020 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital slumped 98.45% in 2021 and surged 180.77% in 2024, its largest moves.
- Tracing LGND's Invested Capital over 5 years: stood at $6.7 million in 2020, then tumbled by 98.45% to $104000.0 in 2021, then slumped by 51.92% to $50000.0 in 2022, then slumped by 48.0% to $26000.0 in 2023, then surged by 180.77% to $73000.0 in 2024.
- Business Quant data shows LGND's Invested Capital at $73000.0 in Q4 2024, $26000.0 in Q4 2023, and $76.8 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 73,000.00 |
| Dec 31, 2023 | 26,000.00 |
| Mar 31, 2023 | 76.79 Mn |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 76.60 Mn |
| Jun 30, 2022 | 114.97 Mn |
| Dec 31, 2021 | 104,000.00 |
| Dec 31, 2020 | 6.71 Mn |
| Jun 30, 2019 | 27.09 Mn |
| Mar 31, 2019 | 26.76 Mn |
| Dec 31, 2018 | 26.43 Mn |
| Sep 30, 2018 | 213.14 Mn |
| Jun 30, 2018 | 210.37 Mn |
| Mar 31, 2018 | 227.55 Mn |
| Dec 31, 2017 | 224.53 Mn |
| Sep 30, 2017 | 221.56 Mn |
| Jun 30, 2017 | 218.63 Mn |
| Mar 31, 2017 | 215.75 Mn |
| Dec 31, 2016 | 212.91 Mn |
| Jun 30, 2016 | 207.36 Mn |